Skip to main content

Bremelanotide Dosage

Medically reviewed by Drugs.com. Last updated on Nov 15, 2024.

Applies to the following strengths: 1.75 mg/0.3 mL

Usual Adult Dose for Hypoactive Sexual Desire Disorder

1.75 mg subcutaneously as needed 45 minutes before anticipated sexual activity


Comments:

Use: For the treatment of acquired, generalized HSDD in premenopausal women not due to a co-existing medical or psychiatric condition, problems with the relationship, or the effects of a medication or drug substance.

Renal Dose Adjustments

Mild renal impairment (eGFR 30 to 89 mL/min/1.73 m2): No adjustment recommended
Severe renal impairment (eGFR less than 30 mL/min/1.73 m2): Use with caution

Liver Dose Adjustments

Mild to moderate hepatic impairment (Child-Pugh A and B): No adjustment recommended
Severe hepatic impairment (Child-Pugh C): Use with caution

Precautions

CONTRAINDICATIONS:


Safety and efficacy have not been established in patients younger than 18 years or in postmenopausal women.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Preparation techniques:

General:
This drug should not be administered more than 8 times per month as more frequent dosing increases the risk for focal hyperpigmentation and the length of time per month when blood pressure is increased.

Monitoring:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.